AIMSEN files for listing on the HKEX Main Board; Tianxing Medical passes HKEX Main Board hearing | HKEX Morning Brief

｜Thursday, April 9, 2026｜

NO.1Amison files for listing on the Hong Kong Stock Exchange Main Board

According to a Hong Kong Stock Exchange announcement on April 7, Wuhan Amison Life Technology Co., Ltd.-B (hereinafter referred to as Amison) has submitted an application for listing on the Main Board of the Hong Kong Stock Exchange. The joint sponsors are CCB International and BOCOM International. According to the prospectus, Amison is an early cancer detection company strategically focused on cancers with high incidence and high mortality rates.

Commentary：Amison’s listing in Hong Kong will help accelerate its R&D implementation and market expansion.

No. 2Tianxing Medical passes the Hong Kong Stock Exchange Main Board hearing

According to a Hong Kong Stock Exchange disclosure on April 7, Beijing Tianxing Medical Co., Ltd. (hereinafter referred to as Tianxing Medical) has passed the Main Board listing hearing of the Hong Kong Stock Exchange. CITIC Securities and CCB International are the joint sponsors. According to the prospectus, Tianxing Medical is a China-based medical device company specializing in sports medicine clinical solutions. According to data from灼识咨询(ChewShiaConsulting), based on 2024 sales revenue, the company ranks as the fourth-largest provider of sports medicine implants and devices in China, with a market share accounting for approximately 6.5% of the Chinese sports medicine implant and device market, and it is also the largest domestic provider of sports medicine implants and devices.

Commentary：With its market share advantage and product portfolio, Tianxing Medical is expected to leverage Hong Kong financing to expand production and strengthen R&D, consolidating its competitive position against imported brands.

No. 3Deloitte: Hong Kong raised HKD 109.9 billion in IPOs in Q1 2026

According to statistics released by Deloitte on April 8, there were 40 new listings on the Hong Kong Stock Exchange in Q1 2026, raising HKD 109.9 billion, ranking first globally. This represents a 167% increase in the number of IPOs compared to 15 new listings raising HKD 18.2 billion in the same period last year, with total funds raised surging by 504%. Among these, three mega-sized IPOs and eight large-sized IPOs contributed nearly 70% of the total funds raised in the first quarter.

Commentary：The number of IPOs (Initial Public Offerings) and the amount of funds raised in Hong Kong's stock market increased year-on-year in the first quarter, highlighting Hong Kong’s pivotal value amid global market volatility.

No. 4Alibaba upgrades its Tongyi Lab to the Tongyi Large Model Business Unit

On April 8, Wu Yongming, CEO of Alibaba Group (HK09988), issued an internal letter announcing organizational adjustments related to AI (Artificial Intelligence). These include the establishment of a new Group Technology Committee, the upgrade of the Tongyi Large Model Business Unit, and acceleration of AI development. According to the internal letter, a Technology Committee was established at the group level, with Wu Yongming serving as the head. To accelerate the overall goal of AI construction, Alibaba also upgraded the Tongyi Lab to the Tongyi Large Model Business Unit, which will be led by Zhou Jingren.

Commentary：This restructuring by Alibaba directly points to an upgrade in its AI strategy, aiming to integrate resources and enhance R&D efficiency, strengthening its long-term competitiveness in the AI sector.

No. 5Hong Kong stock market update:

Disclaimer: The content and data provided in this article are for reference only and do not constitute investment advice. Verify before use. Any actions taken based on this information are at your own risk.

371K Views